NCT05742893Completed
Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders
Comparison of a Speech-Language Pathology Assessment Tool for Pragmatic and Discourse Skills for Patients With Schizophrenic Spectrum Disorders and Other Psychotic Disorders
Source: ClinicalTrials.gov · Last updated 11 Apr 2024
Brief summary (registry, in English)
The scientific literature has largely objectified language disorders in schizophrenia. And more precisely, the impairment of pragmatic and discursive language skills. Currently, there is no standardized language assessment tool specific to these patients. The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 2 Feb 2023
- Start date
- 6 Mar 2023
- Primary completion date
- 6 Mar 2023
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Diseases
- Schizophrenia
- NCT number
- NCT05742893
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 6 Mar 2023 to the primary completion date, 6 Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient who had a change in treatment in the period of less than three months prior to the pass
- Patient with a worsening of the disease in the three months prior to the inclusion visit
Other
- \- Patient hospitalized under restraint
- Patient under guardianship
- Patient who has stopped taking his or her treatment
Who the study is looking for
- Male or female between the ages of 18 and 60
- Patient with a diagnosis of schizophrenic spectrum disorder and other psychotic disorders meeting DSM V criteria
- Patient who has been clinically and treatment stable for at least three months
- Patient who can read and write French
- Patient who is a beneficiary of a social security plan or similar
- Patient with ability to sign free and informed consent
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Nice Coordinator of this site? Confirm its status | Nice | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.